Association of lung field area with mortality in Mycobacterium avium complex lung disease: a longitudinal cohort
Hiroaki Ogata1,2, Takeshi Yamanoue3, Toyoshi Yanagihara4,5
1Department of Respiratory Medicine, NHO Fukuoka National Hospital, 4-39-1 Yakatabaru, Minami-ku, Fukuoka, 811-1394, Japan. md105020@gmail.com.
Background:
Nontuberculous mycobacteria (NTM), particularly the Mycobacterium avium complex (MAC), is becoming a global health burden with increasing incidence worldwide. Previous studies have linked pulmonary function impairment with increased mortality in NTM lung disease, suggesting that lung volume may be a critical predictor of mortality. The objective of this study was to assess the prognostic value of lung field area (LFA) in predicting all-cause mortality among patients with MAC lung disease.
Methods:
We conducted a longitudinal cohort study of 232 patients diagnosed with MAC lung disease at NHO Fukuoka National Hospital from April 1996 to December 2021. Quantitative CT image analysis was performed to measure LFA. Statistical analysis included Kaplan-Meier curves and Cox proportional hazards models to estimate mortality risk, adjusting for demographic and clinical variables.
Results:
Patients with lower LFAs had significantly higher mortality rates (P < 0.01 for a trend), with a multivariable-adjusted hazard ratio of 5.90 (95% CI, 1.85-18.76) for the lowest tertile as compared to the highest. The predicting ability of mean LFA for all-cause death was superior to that of cavitary lesions assessed by low-attenuation areas (LAA), with area under the curve values of 0.77 for LFA versus 0.53 for LAA (P < 0.01).
Conclusion:
Decreased LFA is an independent risk factor for mortality in patients with MAC lung disease, offering better prognostic utility than traditional markers of disease severity such as cavity lesions. These findings highlight the potential for LFA to guide clinical management and risk stratification in MAC lung disease.
More Related Videos
03:38Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
08:46A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation
Published on: July 26, 2017
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
